Fast insight into nanotechnology

Access easily searchable nanoscience data, synthesis methods and literature

indomethacin nanopowder dispersion

Based on

2 Patents
2015 Most recent source

Composition

Image only illustrates the order and placement of components as described in literature.

1

(1-(4-chlorobenzoyl)-5-methoxy-2-methyl-3-indoleacetic acid)

3-indoleacetic acid indomethacin indometacin IndOH IMC IND
Type Single Compound
Formula C19H16ClNO4
Role raw materials

Properties

Applications

Characterization

Method Source

Full content is available to subscribers only

To view content please choose from the following:

Biological effects

Preparation

Method 1

Type: Physical formation
Source:
Starting materials
  • hypodicarbonous acid
  • (1-(4-chlorobenzoyl)-5-methoxy-2-methyl-3-indoleacetic acid)
  • trehalose
Product

indomethacin nanopowder dispersion

Method 2

Type: Physical formation
Source:
Starting materials
  • DK Ester SS™
  • water
  • D-(-)-mannitol
See all (5)
Product

indomethacin nanopowder dispersion

Method 3

Type: Physical formation
Source:
Starting materials
  • DK Ester SS™
  • water
  • D-(-)-mannitol
See all (5)
Product

indomethacin nanopowder dispersion

Method 4

Type: Physical formation
Source:
Starting materials
  • DK Ester SS™
  • water
  • D-(-)-mannitol
See all (5)
Product

indomethacin nanopowder dispersion

Method 5

Type: Physical formation
Source:
Starting materials
  • DK Ester SS™
  • water
  • D-(-)-mannitol
See all (5)
Product

indomethacin nanopowder dispersion

References

Full content is available to subscribers only

To view content please choose from the following:

We use cookies to improve your experience with our site. More information

Sign up for a free trial